Gender differences in urothelial bladder cancer: Effects of natural killer lymphocyte immunity

Charles T. Lutz; Lydia Livas; Steven R. Presnell; Morgan Sexton; Peng Wang

doi:10.3390/jcm10215163

Gender differences in urothelial bladder cancer: Effects of natural killer lymphocyte immunity

Charles T. Lutz, Lydia Livas, Steven R. Presnell, Morgan Sexton, Peng Wang

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

Men are more likely to develop cancer than women. In fact, male predominance is one of the most consistent cancer epidemiology findings. Additionally, men have a poorer prognosis and an increased risk of secondary malignancies compared to women. These differences have been investigated in order to better understand cancer and to better treat both men and women. In this review, we discuss factors that may cause this gender difference, focusing on urothelial bladder cancer (UBC) pathogenesis. We consider physiological factors that may cause higher male cancer rates, including differences in X chromosome gene expression. We discuss how androgens may promote bladder cancer development directly by stimulating bladder urothelium and indirectly by suppressing immunity. We are particularly interested in the role of natural killer (NK) cells in anti-cancer immunity.

Original language	English
Article number	5163
Journal	Journal of Clinical Medicine
Volume	10
Issue number	21
DOIs	https://doi.org/10.3390/jcm10215163
State	Published - Nov 1 2021

Bibliographical note

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Funding

Funding: Department of Pathology and Laboratory Medicine, University of Kentucky. The UK Flow Cytometry and Immune Monitoring core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center, and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. Department of Pathology and Laboratory Medicine, University of Kentucky. The UK Flow Cytometry and Immune Monitoring core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center, and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center.

Funders	Funder number
Office of the Vice President for Research
National Childhood Cancer Registry – National Cancer Institute	P30 CA177558
University of Kentucky
University of Kentucky Markey Cancer Center

Keywords

Androgens
Immunosuppression
Natural killer cells
Sex factors
Urothelial bladder cancer
X chromosome

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/jcm10215163

Cite this

@article{717ff0877d724b19a229fe0214566b2e,

title = "Gender differences in urothelial bladder cancer: Effects of natural killer lymphocyte immunity",

abstract = "Men are more likely to develop cancer than women. In fact, male predominance is one of the most consistent cancer epidemiology findings. Additionally, men have a poorer prognosis and an increased risk of secondary malignancies compared to women. These differences have been investigated in order to better understand cancer and to better treat both men and women. In this review, we discuss factors that may cause this gender difference, focusing on urothelial bladder cancer (UBC) pathogenesis. We consider physiological factors that may cause higher male cancer rates, including differences in X chromosome gene expression. We discuss how androgens may promote bladder cancer development directly by stimulating bladder urothelium and indirectly by suppressing immunity. We are particularly interested in the role of natural killer (NK) cells in anti-cancer immunity.",

keywords = "Androgens, Immunosuppression, Natural killer cells, Sex factors, Urothelial bladder cancer, X chromosome",

author = "Lutz, {Charles T.} and Lydia Livas and Presnell, {Steven R.} and Morgan Sexton and Peng Wang",

note = "Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = nov,

day = "1",

doi = "10.3390/jcm10215163",

language = "English",

volume = "10",

number = "21",

}

TY - JOUR

T1 - Gender differences in urothelial bladder cancer

T2 - Effects of natural killer lymphocyte immunity

AU - Lutz, Charles T.

AU - Livas, Lydia

AU - Presnell, Steven R.

AU - Sexton, Morgan

AU - Wang, Peng

PY - 2021/11/1

Y1 - 2021/11/1

N2 - Men are more likely to develop cancer than women. In fact, male predominance is one of the most consistent cancer epidemiology findings. Additionally, men have a poorer prognosis and an increased risk of secondary malignancies compared to women. These differences have been investigated in order to better understand cancer and to better treat both men and women. In this review, we discuss factors that may cause this gender difference, focusing on urothelial bladder cancer (UBC) pathogenesis. We consider physiological factors that may cause higher male cancer rates, including differences in X chromosome gene expression. We discuss how androgens may promote bladder cancer development directly by stimulating bladder urothelium and indirectly by suppressing immunity. We are particularly interested in the role of natural killer (NK) cells in anti-cancer immunity.

AB - Men are more likely to develop cancer than women. In fact, male predominance is one of the most consistent cancer epidemiology findings. Additionally, men have a poorer prognosis and an increased risk of secondary malignancies compared to women. These differences have been investigated in order to better understand cancer and to better treat both men and women. In this review, we discuss factors that may cause this gender difference, focusing on urothelial bladder cancer (UBC) pathogenesis. We consider physiological factors that may cause higher male cancer rates, including differences in X chromosome gene expression. We discuss how androgens may promote bladder cancer development directly by stimulating bladder urothelium and indirectly by suppressing immunity. We are particularly interested in the role of natural killer (NK) cells in anti-cancer immunity.

KW - Androgens

KW - Immunosuppression

KW - Natural killer cells

KW - Sex factors

KW - Urothelial bladder cancer

KW - X chromosome

UR - http://www.scopus.com/inward/record.url?scp=85118358549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118358549&partnerID=8YFLogxK

U2 - 10.3390/jcm10215163

DO - 10.3390/jcm10215163

M3 - Article

AN - SCOPUS:85118358549

VL - 10

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

IS - 21

M1 - 5163

ER -

Gender differences in urothelial bladder cancer: Effects of natural killer lymphocyte immunity

Abstract

Bibliographical note

Funding

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this